Login / Signup

Multimodal Imaging Based Predictors for the Development of Choroidal Neovascularization in Patients with Central Serous Chorioretinopathy.

Sonny CaplashThamolwan SurakiatchanukulSupriya AroraDmitrii S MaltsevSumit Randhir SinghNiroj Kumar SahooDeepika ParameshwarappaAlexei N KulikovClaudio IovinoFilippo TattiRamkailash GujarRamesh VenkateshNikitha Gurram ReddyRam SnehithEnrico PeirettiMarco LupidiJay Chhablani
Published in: Journal of clinical medicine (2023)
This study evaluated predictors for choroidal neovascularization (CNV) associated with central serous chorioretinopathy (CSCR) based on multimodal imaging. A retrospective multicenter chart review was conducted on 134 eyes of 132 consecutive patients with CSCR. Eyes were classified as per the multimodal imaging-based classification of CSCR at baseline into simple/complex CSCR and primary episode/recurrent/resolved CSCR. Baseline characteristics of CNV and predictors were evaluated with ANOVA. In 134 eyes with CSCR, 32.8% had CNV ( n = 44) with 72.7% having complex CSCR ( n = 32), 22.7% having simple ( n = 10) and 4.5% having atypical ( n = 2). Primary CSCR with CNV were older (58 vs. 47, p = 0.00003), with worse visual acuity (0.56 vs. 0.75, p = 0.01) and of longer duration (median 7 vs. 1, p = 0.0002) than those without CNV. Similarly, recurrent CSCR with CNV were older (61 vs. 52, p = 0.004) than those without CNV. Patients with complex CSCR were 2.72 times more likely to have CNV than patients with simple CSCR. In conclusion, CNV associated with CSCR was more likely in complex CSCR and older age of presentation. Both primary and recurrent CSCR are implicated in CNV development. Patients with complex CSCR were 2.72 times more likely to have CNV than patients with simple CSCR. Multimodal imaging-based classification of CSCR supports detailed analysis of associated CNV.
Keyphrases
  • optical coherence tomography
  • high resolution
  • machine learning
  • high grade
  • physical activity
  • community dwelling
  • diabetic retinopathy
  • mass spectrometry
  • clinical trial
  • fluorescence imaging